BioPharma Dive November 22, 2024
Despite plans to shutter 1,200 stores, the company’s chief clinical trials officer said the pharmacy giant remains committed to aiding drug research.
Retail pharmacy giants have been straining under the intense headwinds hitting the industry this year — and Walgreens’ most recent earnings provided another case in point.
The company said in October that it plans to close about 1,200 lower-performing stores over the next three years, citing changing consumer habits, rising competition from chains like Walmart and battles with pharmacy benefit managers over reimbursement as chief challenges. The pharmacy chain operates nearly 9,000 stores in the U.S.
As Walgreens attempts to regain footing, the company plans to return its focus to its “legacy strength as a retail pharmacy-led company,”...
Today's Sponsors
Today's Sponsor